Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research.

Lin HH, Zhang GL, Tongchusak S, Reinherz EL, Brusic V.

BMC Bioinformatics. 2008 Dec 12;9 Suppl 12:S22. doi: 10.1186/1471-2105-9-S12-S22.

2.

Bioinformatics tools for identifying class I-restricted epitopes.

Martin W, Sbai H, De Groot AS.

Methods. 2003 Mar;29(3):289-98. Review.

PMID:
12725794
3.

Predicting peptide binding to Major Histocompatibility Complex molecules.

Liao WW, Arthur JW.

Autoimmun Rev. 2011 Jun;10(8):469-73. doi: 10.1016/j.autrev.2011.02.003. Epub 2011 Feb 16. Review.

PMID:
21333759
4.

Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: a biotech's challenge.

Iurescia S, Fioretti D, Fazio VM, Rinaldi M.

Biotechnol Adv. 2012 Jan-Feb;30(1):372-83. doi: 10.1016/j.biotechadv.2011.06.020. Epub 2011 Jul 2. Review.

PMID:
21745560
5.

T-cell epitope prediction methods: an overview.

Desai DV, Kulkarni-Kale U.

Methods Mol Biol. 2014;1184:333-64. doi: 10.1007/978-1-4939-1115-8_19. Review.

PMID:
25048134
6.

Evaluating the immunogenicity of protein drugs by applying in vitro MHC binding data and the immune epitope database and analysis resource.

Paul S, Kolla RV, Sidney J, Weiskopf D, Fleri W, Kim Y, Peters B, Sette A.

Clin Dev Immunol. 2013;2013:467852. doi: 10.1155/2013/467852. Epub 2013 Oct 8. Review.

7.

Computer-aided design of T-cell epitope-based vaccines: addressing population coverage.

Oyarzun P, Kobe B.

Int J Immunogenet. 2015 Oct;42(5):313-21. doi: 10.1111/iji.12214. Epub 2015 Jul 24. Review.

PMID:
26211755
8.

Bioinformatics resources and tools for conformational B-cell epitope prediction.

Sun P, Ju H, Liu Z, Ning Q, Zhang J, Zhao X, Huang Y, Ma Z, Li Y.

Comput Math Methods Med. 2013;2013:943636. doi: 10.1155/2013/943636. Epub 2013 Jul 21. Review.

9.

HLA-DR: molecular insights and vaccine design.

Stern LJ, Calvo-Calle JM.

Curr Pharm Des. 2009;15(28):3249-61. Review.

10.

HLA-binding properties of tumor neoepitopes in humans.

Fritsch EF, Rajasagi M, Ott PA, Brusic V, Hacohen N, Wu CJ.

Cancer Immunol Res. 2014 Jun;2(6):522-9. doi: 10.1158/2326-6066.CIR-13-0227. Epub 2014 Mar 3. Review.

11.

Machine Learning Methods for Predicting HLA-Peptide Binding Activity.

Luo H, Ye H, Ng HW, Shi L, Tong W, Mendrick DL, Hong H.

Bioinform Biol Insights. 2015 Oct 11;9(Suppl 3):21-9. doi: 10.4137/BBI.S29466. eCollection 2015. Review.

12.

Applications for T-cell epitope queries and tools in the Immune Epitope Database and Analysis Resource.

Kim Y, Sette A, Peters B.

J Immunol Methods. 2011 Nov 30;374(1-2):62-9. doi: 10.1016/j.jim.2010.10.010. Epub 2010 Oct 31. Review.

13.

An overview of bioinformatics tools for epitope prediction: implications on vaccine development.

Soria-Guerra RE, Nieto-Gomez R, Govea-Alonso DO, Rosales-Mendoza S.

J Biomed Inform. 2015 Feb;53:405-14. doi: 10.1016/j.jbi.2014.11.003. Epub 2014 Nov 10. Review.

14.

Definition of CD4 Immunosignatures Associated with MTB.

Lindestam Arlehamn CS, Sette A.

Front Immunol. 2014 Mar 24;5:124. doi: 10.3389/fimmu.2014.00124. eCollection 2014. Review.

15.

In silico models for B-cell epitope recognition and signaling.

Ansari HR, Raghava GP.

Methods Mol Biol. 2013;993:129-38. doi: 10.1007/978-1-62703-342-8_9. Review.

PMID:
23568468
16.

How frequently are predicted peptides actually recognized by CD8 cells?

Moldovan I, Targoni O, Zhang W, Sundararaman S, Lehmann PV.

Cancer Immunol Immunother. 2016 Jul;65(7):847-55. doi: 10.1007/s00262-016-1840-7. Epub 2016 Apr 23. Review.

17.

Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens.

Liljeroos L, Malito E, Ferlenghi I, Bottomley MJ.

J Immunol Res. 2015;2015:156241. doi: 10.1155/2015/156241. Epub 2015 Oct 7. Review.

18.

Recommendations for evaluation of computational methods.

Jain AN, Nicholls A.

J Comput Aided Mol Des. 2008 Mar-Apr;22(3-4):133-9. doi: 10.1007/s10822-008-9196-5. Epub 2008 Mar 13. Review.

19.

Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors.

Overwijk WW, Wang E, Marincola FM, Rammensee HG, Restifo NP.

J Immunother Cancer. 2013 Jul 29;1:11. doi: 10.1186/2051-1426-1-11. eCollection 2013. Review.

20.

Computational modelling approaches to vaccinology.

Pappalardo F, Flower D, Russo G, Pennisi M, Motta S.

Pharmacol Res. 2015 Feb;92:40-5. doi: 10.1016/j.phrs.2014.08.006. Epub 2014 Sep 16. Review.

PMID:
25224605
Items per page

Supplemental Content

Write to the Help Desk